Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $25,971 | 4 | 91.1% |
| Travel and Lodging | $1,582 | 3 | 5.5% |
| Food and Beverage | $960.53 | 7 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $11,696 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $6,353 | 6 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $5,634 | 3 | $0 (2024) |
| AstraZeneca UK Limited | $4,750 | 1 | $0 (2020) |
| Aerie Pharmaceuticals, Inc. | $37.35 | 1 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $31.37 | 1 | $0 (2017) |
| Zimmer Biomet Holdings, Inc. | $12.83 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,986 | 9 | Novartis Pharmaceuticals Corporation ($6,353) |
| 2020 | $4,750 | 1 | AstraZeneca UK Limited ($4,750) |
| 2018 | $11,746 | 3 | GENZYME CORPORATION ($11,696) |
| 2017 | $31.37 | 1 | Alexion Pharmaceuticals, Inc. ($31.37) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $5,025.00 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $601.41 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $290.75 | General |
| 11/08/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $207.28 | General |
| 11/07/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $139.99 | General |
| 10/15/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $773.54 | General |
| Category: Nephrology | ||||||
| 09/27/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $360.00 | General |
| Category: Nephrology | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $88.24 | General |
| 08/21/2020 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $4,750.00 | General |
| 08/29/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $37.35 | General |
| Category: Ophthalmology | ||||||
| 08/02/2018 | GENZYME CORPORATION | FABRAZYME (Drug) | Consulting Fee | Cash or cash equivalent | $11,696.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 01/05/2018 | Zimmer Biomet Holdings, Inc. | Eztetic (Device) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Dental | ||||||
| 03/05/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 409 | 1,259 | $73,697 | $25,339 |
| 2022 | 7 | 776 | 2,415 | $142,612 | $50,266 |
| 2021 | 7 | 1,319 | 4,243 | $239,105 | $86,220 |
| 2020 | 7 | 1,424 | 4,480 | $253,817 | $94,860 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2023 | 77 | 628 | $47,037 | $13,343 | 28.4% |
| 88348 | Electron microscopy for diagnosis | Facility | 2023 | 64 | 64 | $6,858 | $3,614 | 52.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 77 | 371 | $7,227 | $3,254 | 45.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 78 | 78 | $4,735 | $2,129 | 45.0% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2023 | 77 | 77 | $5,767 | $2,030 | 35.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 25 | 25 | $1,264 | $638.25 | 50.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 11 | 16 | $809.12 | $330.83 | 40.9% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2022 | 145 | 1,215 | $91,004 | $26,450 | 29.1% |
| 88348 | Electron microscopy for diagnosis | Facility | 2022 | 127 | 130 | $13,930 | $7,473 | 53.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 143 | 693 | $13,500 | $6,220 | 46.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 144 | 147 | $8,923 | $4,105 | 46.0% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2022 | 146 | 149 | $11,160 | $4,018 | 36.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 55 | 59 | $2,984 | $1,536 | 51.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 16 | 22 | $1,113 | $463.91 | 41.7% |
| 88350 | Antibody evaluation, each additional single antibody stain procedure | Facility | 2021 | 247 | 1,983 | $148,527 | $43,871 | 29.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 250 | 1,425 | $27,759 | $12,930 | 46.6% |
| 88348 | Electron microscopy for diagnosis | Facility | 2021 | 213 | 213 | $22,823 | $12,474 | 54.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 250 | 250 | $15,175 | $7,057 | 46.5% |
| 88346 | Antibody evaluation, initial single antibody stain procedure | Facility | 2021 | 247 | 247 | $18,500 | $6,759 | 36.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 91 | 91 | $4,602 | $2,391 | 52.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 21 | 34 | $1,719 | $736.82 | 42.9% |
| 88350 | Antibody evaluation | Facility | 2020 | 261 | 2,077 | $155,567 | $47,681 | 30.6% |
| 88348 | Electron microscopy for diagnosis | Facility | 2020 | 231 | 232 | $25,410 | $13,986 | 55.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2020 | 265 | 1,483 | $28,889 | $13,863 | 48.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 264 | 266 | $16,146 | $7,785 | 48.2% |
About Dr. Christopher Larsen, MD
Dr. Christopher Larsen, MD is a Anatomic Pathology healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447434840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Larsen, MD has received a total of $28,514 in payments from pharmaceutical and medical device companies, with $11,986 received in 2024. These payments were reported across 14 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($25,971).
As a Medicare-enrolled provider, Larsen has provided services to 3,928 Medicare beneficiaries, totaling 12,397 services with total Medicare billing of $256,685. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location Little Rock, AR
- Active Since 12/20/2007
- Last Updated 04/07/2021
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1447434840
Products in Payments
- FABRAZYME (Drug) $11,696
- TARPEYO (Drug) $5,634
- Rhopressa (Drug) $37.35
- SOLIRIS (Drug) $31.37
- Eztetic (Device) $12.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Little Rock
Patrick Walker, M.d, M.D
Anatomic Pathology — Payments: $21,488
Bobby Boyanton, M.d, M.D
Anatomic Pathology — Payments: $6,560
Charles Quick, Md, MD
Anatomic Pathology — Payments: $4,651
Mrs. Clarissa Cassol, Md, MD
Anatomic Pathology — Payments: $2,858
Dr. Fred Silva, M.d, M.D
Anatomic Pathology — Payments: $665.41
Chien Chen, Md, MD
Anatomic Pathology — Payments: $94.97